Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions

GlaucomaOcular Hypertension

Interventions

DRUG

Azarga (brinzolamide 1% / timolol 0.5%)

Dosed twice daily at 9:00 AM and 9:00 PM for 12 weeks

DRUG

Cosopt (dorzolamide 2% / timolol 0.5%)

Dosed twice daily at 9:00 AM and 9:00 PM for 12 weeks

Trial Locations (1)

Mississauga